StephenACullinanMD

PubMed

• 58 citations
  Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)
  Stuart M. Lichtman, Donna Hollis, Antonius A. Miller, Gary L. Rosner, Chris A. Rhoades, Eric P. Lester, Frederick Millard, John C. Byrd, Stephen A. Cullinan, D. Marc R...> ;Journal of Clinical Oncology. 2006 Apr 20
• 90 citations
  Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis
  James N. Ingle, Harry J. Long, Donald I. Twito, Daniel J. Schaid, Stephen A. Cullinan, James G. Gerstner, James E. Krook, James A. Mailliard, Loren K. Tschetter, H E W...> ;Cancer. 1991 Feb 15
• 167 citations
  A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
  Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand, Allan J. Schutt, James E. Krook, John F. Foley, B. Norris, Carl G. Kardinal, Loren K. Tschetter, John F. Barlow> ;Cancer. 1990 May 15
• Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer.
  Everson LK, Jett JR, O'Fallon JR, Krook JE, Dalton RJ, Mailliard JA, Tschetter LK, Cullinan SA, Gerstner JB, Morton RF> ;Am. J. Clin. Oncol.. 1989-08-01
• 7 citations
  Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer
  Robert F. Marschke, James N. Ingle, Daniel J. Schaid, James E. Krook, James A. Mailliard, Stephen A. Cullinan, Delano M. Pfeifle, Henry J. Votava, Larry P. Ebbert, Har...> ;Cancer. 1989 May 15
• 26 citations
  Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breas...
  James N. Ingle, L K Everson, H. Sam Wieand, Stephen A. Cullinan, Lester E. Wold, Jeffrey B. Hagen, J. Kirk Martin, James E. Krook, Robert G. Fitzgibbons, John F. Foley...> ;Cancer. 1989 Apr 1
• 19 citations
  Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer
  Jan C. Buckner, James N. Ingle, L K Everson, Judith R. O'Fallon, Stephen A. Cullinan, David L. Ahmann, James E. Krook, Delano M. Pfeifle> ;Breast Cancer Research and Treatment. 1989 Mar 1
• 2 citations
  Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinoma
  Robert F. Marschke, Larry K. Kvols, Stephen A. Cullinan, John A. Laurie, James A. Mailliard, Loren K. Tschetter, Michael J. O'Connell> ;Medical and Pediatric Oncology. 1988 Jan 1
• 20 citations
  Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment.
  John H. Edmonson, James E. Krook, Joan F. Hilton, Harry J. Long, Stephen A. Cullinan, L K Everson, George D. Malkasian> ;Cancer Treatment Reports. 1986 Aug 1
• Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage ...
  Edmonson JH, McCormack GW, Fleming TR, Cullinan SA, Krook JE, Malkasian GD, Podratz KC, Mailliard JA, Jefferies JA, Barlow JF> ;Cancer Treat Rep. 1985-11-01
• 312 citations
  A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorour...
  Stephen A. Cullinan, Charles G. Moertel, Thomas R. Fleming, Joseph Rubin, James E. Krook, L K Everson, H E Windschitl, Donald I. Twito, Robert F. Marschke, John F. Fol...> ;JAMA. 1985 Apr 12
• 14 citations
  Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer
  James E. Krook, James N. Ingle, Green Sj, Bowman Wd, L K Everson, H E Windschitl, Marschke Rf, J A Laurie, Stephen A. Cullinan, Pfeifle Dm> ;Cancer Treatment Reports. 1985 Apr 1
• 14 citations
  Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
  James E. Krook, Thomas R. Fleming, R. T. Eagan, Stephen A. Cullinan, Pfeifle Dm, T. Elliott, P. Etzell> ;Cancer Treatment Reports. 1984 Mar 1
• 12 citations
  Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
  H E Windschitl, Scott M, Allan J. Schutt, Greg W. McCormack, L K Everson, Stephen A. Cullinan, Gerstner J, James E. Krook, J A Laurie, Shreck R> ;Cancer Treatment Reports. 1983 Nov 1
• 11 citations
  Neuromyopathy of cyanide intoxication due to “laetrile” (amygdalin). A clinicopathologic study
  Uma P. Kalyanaraman, K. Kalyanaraman, Stephen A. Cullinan, John M. McLean> ;Cancer. 1983 Jun 1
• 1 citations
  Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
  H E Windschitl, James E. Krook, L K Everson, Stephen A. Cullinan, Scott M> ;Cancer Treatment Reports. 1982 Dec 1
• 2 citations
  Phase II study of cytosine arabinoside in advanced large bowel cancer.
  Stephen A. Cullinan, Michael J. O'Connell, Charles G. Moertel, Allan J. Schutt, Richard G. Hahn, Reitemeier Rj, Stephen Frytak, Joseph Rubin> ;Cancer Treatment Reports. 1977 Dec 1
• 28 citations
  Acute pulmonary hypersensitivity to carbamazepine.
  Stephen A. Cullinan, George C. Bower> ;Chest. 1975 Oct 1
• Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and ...
  O'Connell, M. J., Klaassen, D. J., Everson, L. K., Cullinan, S., Wieand, H. S.> ;NCI Monogr. 1987
• Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
  Ingle, J. N., Twito, D. I., Schaid, D. J., Cullinan, S. A., Krook, J. E., Mailliard, J. A., Marschke, R. F., Long, H. J., Gerstner, J. G., Windschitl, H. E.> ;J Clin Oncol. 1988 May
• Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausa...
  Ingle, J. N., Everson, L. K., Wieand, H. S., Martin, J. K., Votava, H. J., Wold, L. E., Krook, J. E., Cullinan, S. A., Paulsen, J. K., Twito, D. I.> ;J Clin Oncol. 1988 Sep
• A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
  Buroker, T. R., Moertel, C. G., Fleming, T. R., Everson, L. K., Cullinan, S. A., Krook, J. E., Mailliard, J. A., Marschke, R. F., Klaassen, D. J., Laurie, J. A.> ;J Clin Oncol. 1985 Dec
• Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
  Poon, M. A., O'Connell, M. J., Moertel, C. G., Wieand, H. S., Cullinan, S. A., Everson, L. K., Krook, J. E., Mailliard, J. A., Laurie, J. A., Tschetter, L. K.> ;J Clin Oncol. 1989 Oct
• FAM therapy for advanced gastric cancer: an ideal standard?
  Cullinan, S. A., Moertel, C. G.> ;J Clin Oncol. 1985 Jun 01
• A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
  Krook, J. E., Jett, J. R., Fleming, T. R., Dalton, R. J., Marschke, R. F., Cullinan, S. A., Windschitl, H. E., Everson, L. K., Brunk, F. S., Laurie, J. A.> ;J Clin Oncol. 1985 Jun 01
• Join now to see all